Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor β signaling

Endocrinology

Volumn 152, Issue 9, 2011, Pages 3409-3421

  Rahal, Omar M ^a,c   Simmen, Rosalia C M ^a,b,c  

^a Interdisciplinary Biomedical Sciences Program   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ADIPONECTIN; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN P53; SOYBEAN PROTEIN; STAT3 PROTEIN; SURVIVIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EPITHELIUM CELL; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ISOLATION; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; MAMMARY GLANDS, ANIMAL; MICE; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 80052437272     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1085     Document Type: Article

References (72)

1. Galanis DJ, Kolonel LN, Lee J, Le Marchand L 1998 Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Cause Control 9:217-224 (Pubitemid 28160977)
2. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC 1997 Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407-1411 (Pubitemid 27475968)
3. Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER, Willett WC 1997 Body size and risk of breast cancer. Am J Epidemiol 145:1011-1019 (Pubitemid 27215484)
4. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL 2002 Body mass and stage of breast cancer at diagnosis. Int J Cancer 98:279-283 (Pubitemid 34150814)
5. Cui Y, Whiteman MK, Langenberg P, Sexton M, Tkaczuk KH, Flaws JA, Bush TL 2002 Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med 11:527-536
6. Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, Chappuis PO, Ceschi M, Ess S, Castiglione M, Rapiti E, Verkooijen HM 2010 Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res Treat 120:185-193
7. Trayhurn P, Beattie JH 2001 Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329-339 (Pubitemid 32772448)
8. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (Pubitemid 38766330)
9. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83 (Pubitemid 29299050)
10. Barb D, Pazaitou-Panayiotou K, Mantzoros CS 2006 Adiponectin: A link between obesity and cancer. Expert Opin Investig Drugs 15:917-931
11. Körner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS 2007 Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041-1048 (Pubitemid 46465681)
12. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS 2006 Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109-114
13. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D 2004 Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102-1107 (Pubitemid 38368397)
14. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S 2003 Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699-5704 (Pubitemid 37499493)
15. Goldstein BJ, Scalia R 2004 Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89:2563-2568 (Pubitemid 38766332)
16. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R 2006 Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345:271-279
17. Liu J, Lam JB, Chow KH, Xu A, Lam KS, Moon RT, Wang Y 2008 Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis 29:2195-2202
18. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A 2006 Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66:11462-11470
19. Lam JB, Chow KH, Xu A, Lam KS, Liu J, Wong NS, Moon RT, Shepherd PR, Cooper GJ, Wang Y 2009 Adiponectin haploinsufficiency promotes mammary tumor Development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One 4:e4968
20. Harvell DM, Strecker TE, Tochacek M, Xie B, Pennington KL, McComb RD, Roy SK, Shull JD 2000 Rat strain-specific actions of 17β-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97:2779-2784
21. Matthews J, Gustafsson JA 2003 Estrogen signaling: A subtle balance between ERα and ER β. Mol Interv 3:281-292
22. Katzenellenbogen BS, Frasor J 2004 Therapeutic targeting in the estrogen receptor hormonal pathway. Semin Oncol 31:28-38 (Pubitemid 38543938)
23. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H 2000 Expression levels of estrogen receptor-α, estrogen receptor-β, coactivators, and corepressors in breast cancer. Clin Cancer Res 6:512-518 (Pubitemid 30111472)
24. Saji S, Hirose M, Toi M 2005 Clinical significance of estrogen receptor β in breast cancer. Cancer Chemother Pharmacol 56(Suppl 1):21-26
25. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F 2001 ERßinhibits proliferation and invasion of breast cancer cells. Endocrinology 142:4120-4130 (Pubitemid 32802685)
26. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P 2004 Loss of ERßexpression as a common step in estrogen- Dependent tumor progression. Endocr Relat Cancer 11:537-551 (Pubitemid 39331282)
27. Skliris GP, Munot K, Bell SM, Carder PJ, Lane S, Horgan K, Lansdown MR, Parkes AT, Hanby AM, Markham AF, Speirs V 2003 Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 201:213-220 (Pubitemid 37258932)
28. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Wärri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA 2002 Estrogen receptor β in breast cancer. Endocr Relat Cancer 9:1-13
29. Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA, Rochefort H 2005 Increased estrogen receptor βcx expression during mammary carcinogenesis. Clin Cancer Res 11:3170-3174 (Pubitemid 40637201)
30. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S 2000 Quantitative analysis of estrogen receptor-βmRNA and its variants in human breast cancers. Int J Cancer 88:733-736
31. Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P, Rochefort H 2001 Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541 (Pubitemid 32685835)
32. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95:15677-15682 (Pubitemid 29018759)
33. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, MäkeläS, Warner M, Gustafsson JA 2003 Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 100:6694-6699 (Pubitemid 36675339)
34. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510 (Pubitemid 27449239)
35. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG, Kushner PJ 2002 Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277:24353-24360 (Pubitemid 34951956)
36. Lindberg MK, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2003 Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "ying yang" relationship between ERα and ERβ in mice. Mol Endocrinol 17:203-208 (Pubitemid 36187395)
37. Chang EC, Frasor J, Komm B, Katzenellenbogen BS 2006 Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147:4831-4842 (Pubitemid 44402189)
38. Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA 2008 A genome-wide study of the repressive effects of estrogen receptor β on estrogen receptor α signaling in breast cancer cells. Oncogene 27:1019-1032 (Pubitemid 351225390)
39. Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET 2007 Inhibitory effects of estrogen receptor β on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 9:R25
40. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS 2008 Estrogen receptors α and βas determinants of gene expression: Influence of ligand, dose, and chromatin binding. Mol Endocrinol 22:1032-1043 (Pubitemid 351629605)
41. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA 2004 Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101:1566-1571 (Pubitemid 38236167)
42. Sotoca AM, Van den Berg H, Vervoort J, Van der Saag P, Ström A, Gustafsson JA, Rietjens I, Murk AJ 2008 Influence of cellular ERα/ERβratio on the ERα-agonist induced proliferation of human T47D breast cancer cells. Toxicol Sci 105:303-311
43. Sotoca AM, Geipke MD, Boeren S, Strom A, Gustaffson JA, Murk AJ, Rietiens IM, Vervoort J 2011 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics 10:M110.002170
44. Lamartiniere CA 2000 Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71:1705S-1707S; discussion 1708S-1709S
45. Cotroneo MS, Wang J, Fritz WA, Eltoum IE, Lamartiniere CA 2002 Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23:1467-1474 (Pubitemid 35021226)
46. Routledge EJ, White R, Parker MG, Sumpter JP 2000 Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ. J Biol Chem 275:35986-35993
47. Sotoca AM, Geipke MD, Boeren S, Strom A, Gustafsson JA, Murk AJ, Rietiens IM, Vervoort J 2011 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics 10:M110.002170
48. Treeck O, Lattrich C, Juhasz-Boess I, Buchholz S, Pfeiler G, Ortmann O 2008 Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer 99:1246-1250
49. Reeves PG, Nielsen FH, Fahey Jr GC 1993 AIN-93 purified diets for laboratory rodents: final report of the American institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951 (Pubitemid 23342492)
50. Su Y, Simmen RC 2009 Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates β-catenin signaling in mammary epithelial cells. Carcinogenesis 30:331-339
51. Dave B, Eason RR, Till SR, Geng Y, Velarde MC, Badger TM, Simmen RC 2005 The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26:1793-1803 (Pubitemid 41487996)
52. Rahal OM, Simmen RC 2010 PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 31:1491-1500
53. Velarde MC, Iruthayanathan M, Eason RR, Zhang D, Simmen FA, Simmen RC 2006 Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Kruppel-like factor 9/basic transcription element binding protein-1. Endocrinology 147:1969-1978
54. Su Y, Shankar K, Simmen RC 2009 Early soy exposure via maternal diet regulates rat mammary epithelial differentiation by paracrine signaling from stromal adipocytes. J Nutr 139:945-951
55. Simmen RC, Eason RR, Till SR, Chatman Jr L, Velarde MC, Geng Y, Korourian S, Badger TM 2005 Inhibition of NMU-induced mammary tumorigenesis by dietary soy. Cancer Lett 224:45-52 (Pubitemid 40720366)
56. Su Y, Eason RR, Geng Y, Till SR, Badger TM, Simmen RC 2007 In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis. Carcinogenesis 28:1046-1051 (Pubitemid 47072189)
57. Chandran M, Phillips SA, Ciaraldi T, Henry RR 2003 Adiponectin: More than just another fat cell hormone? Diabetes Care 26:2442-2450 (Pubitemid 36993340)
58. Wang Y, Lam KS, Xu A 2007 Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Res 17:280-282 (Pubitemid 46639924)
59. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R 2006 Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12:11-19 (Pubitemid 43166170)
60. Debnath J, Muthuswamy SK, Brugge JS 2003 Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256-268 (Pubitemid 36677560)
61. Miyazaki T, Bub JD, Uzuki M, Iwamoto Y 2005 Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun 333:79-87 (Pubitemid 40813449)
62. Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA 2006 Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res 12:20-28 (Pubitemid 43166171)
63. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP 2008 Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98:370-379 (Pubitemid 351161253)
64. Su Y, Simmen FA, Xiao R, Simmen RC 2007 Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics 30:8-16 (Pubitemid 47173284)
65. Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA 2005 Estrogen receptors alfa (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24:6605-6616 (Pubitemid 41486791)
66. Su Y, Shankar K, Rahal O, Simmen RCM 2011 Bidirectional signaling of mammary epithelium and stroma: implications for breast cancer-preventive actions of dietary factors. J Nutr Biochem 22:605-611
67. Shankar K, Kang P, Harrell A, Zhong Y, Marecki JC, Ronis MJ, Badger TM 2010 Maternal overweight programs insulin and adiponectin signaling in the offspring. Endocrinology 151:2577-2589
68. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V, Cossu E, Cavallo MG, Mariotti S, Loche S, Baroni MG 2008 Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 93:3051-3057
69. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss LD, English P, Sattar N, Wilkin TJ 2008 Adiponectin in childhood. Int J Pediatr Obes 3:130-140 (Pubitemid 352015837)
70. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S 2008 Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr 47:356-362
71. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
72. Wang Y, Lobstein T 2006 Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1:11-25